Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
New treatment options for patients with metastatic colorectal cancer
Erin Grothey
, Axel Grothey
Medical Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New treatment options for patients with metastatic colorectal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
New Treatment Options
100%
Metastatic Colorectal Cancer (mCRC)
100%
Panitumumab
100%
Cetuximab
40%
Oncologists
40%
Colorectal Carcinoma
40%
Antitumor Activity
20%
Epidermal Growth Factor Receptor Signaling
20%
Epidermal Growth Factor Receptor
20%
Treatment Strategy
20%
Chemotherapeutic Regimens
20%
U.S. Food
20%
Pivotal Trial
20%
Advanced Colorectal Carcinoma
20%
Receptor-targeted Therapy
20%
Medicine and Dentistry
Metastatic Colorectal Cancer
100%
Panitumumab
100%
Colorectal Carcinoma
60%
Epidermal Growth Factor Receptor
40%
Cetuximab
40%
Oncologist
40%
Clinical Trial
20%
Targeted Therapy
20%
Antineoplastic Activity
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Panitumumab
100%
Colorectal Carcinoma
60%
Epidermal Growth Factor Receptor
40%
Cetuximab
40%
Clinical Trial
20%
Antitumor Activity
20%
Diseases
20%
Immunology and Microbiology
Panitumumab
100%
Epidermal Growth Factor
40%
Cetuximab
40%
Antineoplastic Activity
20%
Neuroscience
Panitumumab
100%
Epidermal Growth Factor Receptor
40%
Cetuximab
40%